Alzheimer’s disease: amino acid levels and brain metabolic status

[1]  K. Herrup,et al.  Glutamine Acts as a Neuroprotectant against DNA Damage, Beta-Amyloid and H2O2-Induced Stress , 2012, PloS one.

[2]  N. Fayed,et al.  Brain Glutamate Levels Are Decreased in Alzheimer’s Disease , 2011, American journal of Alzheimer's disease and other dementias.

[3]  A. Hopper,et al.  Retrograde nuclear accumulation of cytoplasmic tRNA in rat hepatoma cells in response to amino acid deprivation , 2007, Proceedings of the National Academy of Sciences.

[4]  H. Gendelman,et al.  A Functional Transsulfuration Pathway in the Brain Links to Glutathione Homeostasis* , 2006, Journal of Biological Chemistry.

[5]  Lu Shi-min,et al.  Amino Acid Regulation of Gene Expression , 2006 .

[6]  Yuan-Xiang Pan,et al.  Amino Acid Deprivation Induces the Transcription Rate of the Human Asparagine Synthetase Gene through a Timed Program of Expression and Promoter Binding of Nutrient-responsive Basic Region/Leucine Zipper Transcription Factors as Well as Localized Histone Acetylation* , 2004, Journal of Biological Chemistry.

[7]  V. Carraro,et al.  Amino acids as regulators of gene expression: molecular mechanisms. , 2004, Biochemical and biophysical research communications.

[8]  N. Mahy,et al.  In vivo neuroprotective adaptation of the glutamate/glutamine cycle to neuronal death , 2004, Hippocampus.

[9]  Shelly C. Lu,et al.  L-Methionine Availability Regulates Expression of the Methionine Adenosyltransferase 2A Gene in Human Hepatocarcinoma Cells , 2003, Journal of Biological Chemistry.

[10]  R. Ferrante,et al.  Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[11]  L. J. Eldik.  Glia and Alzheimer's disease , 2001, Neurochemistry International.

[12]  R. Dringen,et al.  Metabolism and functions of glutathione in brain , 2000, Progress in Neurobiology.

[13]  Junying Yuan,et al.  Apoptosis in the nervous system , 2000, Nature.

[14]  Pierre Fafournoux,et al.  Amino Acids Control Mammalian Gene Transcription: Activating Transcription Factor 2 Is Essential for the Amino Acid Responsiveness of the CHOP Promoter , 2000, Molecular and Cellular Biology.

[15]  D. Butterfield,et al.  Oxidative Modification of Creatine Kinase BB in Alzheimer’s Disease Brain , 2000, Journal of neurochemistry.

[16]  C. Bergeron,et al.  Caspase-6 Role in Apoptosis of Human Neurons, Amyloidogenesis, and Alzheimer’s Disease* , 1999, The Journal of Biological Chemistry.

[17]  David Smith,et al.  Involvement of Caspases in Proteolytic Cleavage of Alzheimer’s Amyloid-β Precursor Protein and Amyloidogenic Aβ Peptide Formation , 1999, Cell.

[18]  A. Raina,et al.  The role of cell cycle‐mediated events in Alzheimer's disease , 1999, International journal of experimental pathology.

[19]  G. Robertson,et al.  Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. , 1999, Cell.

[20]  R. Tanzi,et al.  Molecular Mechanisms of Dementia , 1997, Nature Medicine.

[21]  B. Hyman.  Anatomy of Pathological Alterations in Alzheimer’s Disease , 1997 .

[22]  R. Nitsch.  From acetylcholine to amyloid: neurotransmitters and the pathology of Alzheimer's disease. , 1996, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[23]  A. Nussler,et al.  Coinduction of nitric oxide synthase and argininosuccinate synthetase in a murine macrophage cell line. Implications for regulation of nitric oxide production. , 1994, The Journal of biological chemistry.

[24]  S. Kish,et al.  Brain S-adenosylmethionine decarboxylase activity is increased in Alzheimer's disease , 1993, Neuroscience Letters.

[25]  L. Andersson,et al.  Ornithine decarboxylase activity is critical for cell transformation , 1992, Nature.

[26]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[27]  W. Markesbery,et al.  Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[28]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[29]  B. Toone,et al.  Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[30]  W. Snow,et al.  The NINCDS‐ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease , 1988, Neurology.

[31]  D. Neary,et al.  Evidence of Glutamatergic Denervation and Possible Abnormal Metabolism in Alzheimer's Disease , 1988, Journal of neurochemistry.

[32]  D. Neary,et al.  Biochemical Assessment of Serotonergic and Cholinergic Dysfunction and Cerebral Atrophy in Alzheimer's Disease , 1983, Journal of neurochemistry.

[33]  A. Hamberger,et al.  Neuron-glia interactions in the biosynthesis and release of transmitter amino acids. , 1981, Advances in biochemical psychopharmacology.

[34]  E. Perry,et al.  Hippocampal Free Amino Acids in Alzheimer's Disease , 1980, Journal of neurochemistry.

[35]  D M Bowen,et al.  Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. , 1976, Brain : a journal of neurology.

[36]  G. Cantoni.  Biological methylation: selected aspects. , 1975, Annual review of biochemistry.

[37]  N. Okumura,et al.  NITROGEN METABOLISM OF THE BRAIN , 1957, Folia psychiatrica et neurologica japonica.

[38]  H. Tallan,et al.  L-cystathionine in human brain. , 1958, The Journal of biological chemistry.